Wegovy Flextouch Pen 0.25 Mg

Wegovy® Flextouch Pen 0.25 mg – Your Starter Dose for Weight Management

The Wegovy (semaglutide) injection 0.25 mg is a GLP -1 medication in the management of chronic weight. Designed for adults falling under obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) who also have significant other weight-related conditions, advised to be used with optimal diet and regular exercise plan.

Flextouch prefilled pen allows a convenient, once-weekly subcutaneous injectable. The 0.25 mg dose serves as the base to the foundation of weight loss journey in the Wegovy treatment titration schedule, which allows you to adapt the medication at the base level, while ensuring minimum load on the gastrointestinal effects.

Key Product Details:

• Dosage: 0.25 mg (initial titration dose)
• Delivery System: Prefilled Wegovy Flextouch Pen
• Administration: Once-weekly subcutaneous injection
• Active Ingredient: Semaglutide (GLP – 1)
• Manufacturer: Novo Nordisk

Effects of Wegovy 0.25 mg on human body?(Semaglutide):

Semaglutide (also found in Rybelsus – oral tablet), the active compound in Wegovy, acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It acts as a natural hormone to the brain, which directly targets the appetite regulation hormone. The process helps to reduce hunger, feeling of being full, and ultimately reduce your overall calorie intake.

Important Usage Information:

Wegovy is a powerful medication that must be used under strict medical supervision. The 0.25 mg dose is intended as a starter dose only to adjust your body to the medication and its effects.Your healthcare provider will guide you through the dosing schedule.

Storage and Handling:

• Store new, unused Wegovy pens in a refrigerator (36°F to 46°F / 2°C to 8°C).
• Do not freeze the pen.
• Keep pens in their original carton to protect from light.
• After first use, the pen can be stored for up to 28 days at room temperature (59°F to 86°F / 15°C to 30°C) or in a refrigerator.

Short Frequently Asked Questions (FAQ):

Q1: What is the Wegovy 0.25 mg pen used for?

A1: The Wegovy 0.25 mg pen is the initial starter dose of semaglutide used in conjunction with diet and exercise for chronic weight management in adults with obesity or overweight conditions with co-morbidities.

Q2: How often is Wegovy 0.25 mg administered?

A2: Wegovy 0.25 mg is administered once weekly via subcutaneous injection.

Q3: Is the 0.25 mg dose sufficient for significant weight loss?

A3: No, the 0.25 mg dose is a starter dose primarily intended to help your body adjust to the medication and reduce gastrointestinal side effects. It is typically not effective for significant weight loss on its own. Your doctor will guide you through a gradual dose escalation.

Q4: Do I need a prescription for Wegovy 0.25 mg?

A4: Yes, Wegovy is a prescription-only medication and requires a valid prescription from a licensed healthcare professional.